|
市場調査レポート
商品コード
1439339
光干渉断層計(OCT)の世界市場:洞察、競合情勢、市場予測:2030年Optical Coherence Tomography (OCT) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
光干渉断層計(OCT)の世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の光干渉断層計(OCT)の市場規模は、2023年に12億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に8.57%のCAGRで拡大し、2030年には20億米ドルに達すると予測されています。OCT市場は、白内障などの眼疾患の有病率の上昇、心筋梗塞などの心血管疾患の増加、世界の高齢者人口の増加、OCTに関する製品開発活動の活発化などの要因によって、プラスの市場成長に向かっています。
OCT市場の主な促進要因の1つは、さまざまな病因に起因する視力障害の有病率の上昇です。国際失明予防機関(IAPB)が提供したデータによると、2020年には世界中で失明に苦しむ人が約11億人となりました。彼らの調査では、約20~30億人が視力を最適化し、社会で機能するために、眼科医療に関するヘルスケア施設へのアクセスを必要としていると推定されています。
OCT装置需要の増加に寄与するもう一つの主要因は、心血管疾患の有病率の上昇です。例えば、世界保健機関(WHO)が提供したデータ(2023年)によると、心血管疾患(CVD)は世界中で最も多くの死亡者数を占め、毎年推定1,790万人の命を奪っています。CVDには、心筋梗塞、うっ血性心不全、急性冠症候群などが含まれます。さらに、WHOの同じデータでは、CVDによる死亡の5人に4人以上が脳卒中と心臓発作を主な原因として挙げており、これらの死亡の3分の1は70歳未満で早死にすると言われています。
心血管疾患の診断を改善し、死亡率を減少させるために、OCT技術は現在、心血管疾患の診断にも使用されています。冠動脈内診断技術である光干渉OCTは、現在の心臓カテーテル検査室において血管の詳細な画像化を提供します。OCTの高い解像度は、他の技術に比べて各構造の優れた描出を提供し、正常および疾患動脈の微細構造を確実に可視化できるため、2024年~2030年の予測期間におけるOCT需要の増加に寄与しています。
当レポートでは、世界の光干渉断層計(OCT)市場について調査し、市場の概要とともに、製品タイプ別、医療専門分野別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Optical Coherence Tomography (OCT) Devices Market By Product Type (Time-Dependent OCT and Fourier-Dependent OCT [Swept-Source OCT and Spectral-Domain OCT], and Others), By Medical Specialty (Opthalmology, Cardiology, and Others), By Application (Clinical Use and Research Use) By End User (Hospitals, Specialty Clinics, Research Institutes, and Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of ocular diseases such as cataracts and increasing prevalence of cardiovascular diseases such as acute myocardial infarction.
Global optical coherence tomography (OCT) devices market was valued at USD 1.22 billion in 2023, growing at a CAGR of 8.57% during the forecast period from 2024 to 2030 to reach USD 2.00 billion by 2030. The OCT devices market is moving towards a positive market growth owing to the factors such as rising prevalence of ocular diseases such as cataracts, growing number of cardiovascular diseases such as myocardial infarction, increasing geriatric population across the globe, and increasing product development activities with respect to OCT devices among others.
OCT Devices Market Dynamics:
One of the main drivers of the OCT devices market is the rising prevalence of vision impairment owing to different disease etiologies. As per the data provided by The International Agency for the Prevention of Blindness (IAPB), in 2020, there were about 1.1 billion people across the globe who were suffering from blindness. It was estimated in their research that approximately 2 to 3 billion people require access to healthcare facilities pertaining to eye care in order to optimize their vision and ability to function in society.
Uncorrected refractive errors, cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy are considered to be the primary causes associated with vision loss. As per the data cited by the World Health Organization, in 2020, cataracts were the prime cause of vision loss in patients above the age of 50 with 15.2 million cases. The increase in the patient population suffering from cataracts is expected to boost the demand for OCT devices as well. This can be ascribed to the fact that OCT devices are heavily employed during cataract surgeries for preoperative planning, intraoperative image-based treatments, and postoperative care. Therefore, the rising prevalence of cataracts the growing need to reduce the disease burden of vision impairment is predicted to aid in the growth of the OCT devices market in the forecast period (2024-2030).
Another key factor contributing in the increasing demand for OCT devices is the rising prevalence of cardiovascular diseases. For instance, as per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) account for the most number of deaths across the globe, accounting for an estimated 17.9 million lives each year. Some of CVDs include myocardial infarction, congestive heart failure, acute coronary syndrome, and other conditions. Furthermore, the same data by the WHO presented that over four out of five CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age.
In order improve the diagnosis of cardiovascular diseases and reduce the mortality rate, OCT technology is now being used in cardiovascular disease diagnosis as well. Optical coherence OCT being an intra-coronary diagnostic technique offers a detailed imaging of blood vessels in the current cardiac catheterization laboratory. The higher resolution of OCT provides superior delineation of each structure compared to other techniques and it can reliably visualize the microstructure of normal and diseased arteries, thereby contributing to the increased demand for OCT devices during the forecast period from 2024-2030.
However, technology-related limitations as well as high cost of devices compared to other counterparts may restrain the OCT devices market growth.
OCT Devices Market Segment Analysis:
Optical Coherence Tomography (OCT) Devices Market by Product Type (Time-Dependent OCT and Fourier-Dependent OCT [Swept-Source OCT and Spectral-Domain OCT], and Others), by Medical Specialty (Ophthalmology, Cardiology, and Others), by Application (Clinical Use and Research Use) by End User (Hospitals, Specialty Clinics, Research Institutes, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of OCT devices market, the swept source optical coherence tomography devices (SS-OCT) are estimated to hold a significant share in the OCT devices market in the forecast period (2024-2030). This can be attributed to the specific features associated with these devices. SS-OCT has the advantage that it works without a spectrometer or line camera. SS-OCT can operate at long wavelengths, achieve faster image speeds and capture a larger image area than SD-OCT. The devices based on this technology work on long wavelengths at 1050 nm which result in less ocular clouding attenuation and an improved depth of field. Commercial SS-OCT devices operate at more than 100,000 scans per second and are finding applications in other clinical specialties such as cardiology, dermatology, and gastroenterology. Moreover, technological advancements in the miniaturization of photonic integrated circuit technology have also contributed in the lowering of costs and compactness of devices as compared to SD-OCT systems. The growing popularity of SS-OCT systems across various medical specialties is further expected to propel the OCT devices market growth in the forecast period.
North America is expected to dominate the overall OCT Devices Market:
Among all the regions, North America is expected to account for the largest share in the OCT Devices market. Owing to significant growth factors such as rising prevalence of geriatric population, increasing prevalence of risk factors associated with cardiovascular as well as ocular diseases such as obesity, hypertension, and diabetes, rising government initiatives, and increased product launches are expected to aid in the growth of the North America OCT Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.
As per the data provided by the Centers for Disease Control and Prevention, in 2018, approximately 116 million people in the United States suffered from hypertension. Hypertension is considered to be one of the key risk factors for the development of both ocular diseases such as cataracts as well as cardiovascular diseases such as heart stroke among others. Therefore, the presence of large patient population suffering from hypertension correlates to the presence of a high patient population suffering from the progression of these diseases which would indicate the growing need for OCT devices that are employed in diseases diagnoses as well as treatment.
Besides the United States, product development activities in other North American countries such as Canada also presents a positive growth environment for the OCT devices market in the regions. For instance, in March 2019, Conavi Medical Inc received a Health Canada Medical Device License for their Novasight Hybrid System. This is the only clinical system that allows for the simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The product launches in the local markets result in significant reduction of costs thereby making them affordable for end users in turn resulting in their high uptake. Therefore, the interplay of various factors such as the presence of large patient population, encouraging reimbursement policies as well as new product launches in the region are going to boost the North America OCT devices market during the forecast period.
OCT Devices Market Key Players:
Some of the key market players operating in the OCT devices market includes Abbott, Terumo Corporation, ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V, Lumedica, Horiba Ltd, Optos (Nikon Co. Ltd), Huvitz Corp, Costruzione Strumenti Oftalmici, HAAG-STREIT GROUP, OPTOPOL Technology Sp. z o.o., Acqiris, Novacam Technologies, Inc., Thorlabs, Inc., Topcon Corporation, SANTEC CORPORATION, Optovue, Incorporated, NIDEK CO., LTD, TOMEY CORPORATION and others.
Recent Developmental Activities in OCT Devices Market:
In October 2022, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined OCT and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.
In August 2022, Abbott received the product approval from the US Food and Drug Administration for their optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon imaging software.
In April 2022, Perimeter Medical Imaging received the Breakthrough Device Designation from the US FDA for their AI's Optical Coherence Tomography (OCT) Imaging System coupled with ImgAssist AI.
Key Takeaways from the OCT Devices Market Report Study
Market size analysis for current OCT devices market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the OCT devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global OCT devices market.
Various opportunities available for the other competitor in the OCT devices market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current OCT devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for OCT devices market growth in the coming future?
Target Audience who can be benefited from this OCT Devices Market Report Study
OCT Devices products providers
Research organizations and consulting companies
OCT Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in OCT devices
Various End-users who want to know more about the OCT devices market and latest technological developments in the OCT devices market.
Frequently Asked Questions for OCT Devices Market:
Optical Coherence Tomography (OCT) is a noninvasive optical imaging modality that provides real-time, 1D depth, 2D cross-sectional, and 3D volumetric images with micron-level resolution and millimeters of imaging depth.
Global optical coherence tomography (OCT) devices market was valued at USD 1.22 billion in 2023, growing at a CAGR of 8.57% during the forecast period from 2024 to 2030 to reach USD 2.00 billion by 2030.
The OCT devices market is slated towards a positive market growth due to factors such as rising prevalence of ocular diseases such as cataracts, growing number of cardiovascular diseases such as myocardial infarction, increasing geriatric population and increasing product development activities among other factors.
Some of the key market players operating in the OCT devices market includes Abbott, Terumo Corporation, ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V, Lumedica, Horiba Ltd, Optos (Nikon Co. Ltd), Huvitz Corp, Costruzione Strumenti Oftalmici, HAAG-STREIT GROUP, OPTOPOL Technology Sp. z o.o., Acqiris, Novacam Technologies, Inc., Thorlabs, Inc., Topcon Corporation, SANTEC CORPORATION, Optovue, Incorporated, NIDEK CO., LTD, TOMEY CORPORATION and others.
North America is expected to hold the highest share in the revenue in the OCT Devices market during the forecast period. Owing to significant growth factors such as rising prevalence of geriatric population, increasing prevalence of risk factors associated with cardiovascular as well as ocular diseases such as obesity, hypertension, and diabetes, rising government initiatives, and increased product launches are expected to aid in the growth of the North America OCT Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.